- “Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report10 September 2019Pharma
Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.
- 09 September 2019Pharma
The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.
- “Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.05 September 2019Pharma
Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.
- “Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.05 September 2019Pharma
Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.
- “Global Small Animal Imaging (In-Vivo) Market is anticipated to grow on account of technological advancements, increasing use of pre-clinical imaging and growing number of research and pharmaceutical companies”, says Visiongain report05 September 2019Pharma
Small animal imaging (In vitro) is a method used in the imaging of biological procedures in living animals that demonstrates changes in cell activity to study drug effects and progression of disease.